ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,136.72
0.56%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Molecular Insight Pharmaceuticals (MM) (MIPI)

  7. Molecular Insight Pharmaceuticals (MM) (MIPI) News

Molecular Insight Pharmaceuticals (MM) (MIPI)

Molecular Insight Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MIPI
DateTimeSourceHeadlineSymbolCompany
21/12/201000:42MarketwiredMolecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB(TM) MarketplaceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/12/201016:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/12/201021:39Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
10/12/201003:46MarketwiredMolecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management ChangesNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201011:02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201000:38MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/11/201022:16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/11/201021:59MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201017:43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201014:31Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201012:21MarketwiredMolecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational ResultsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/11/201021:28Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/11/201021:18MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/10/201022:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/10/201021:49MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201021:51Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201021:30MarketwiredMolecular Insight Pharmaceuticals Data Indicate Trofex(TM) May Enable Visualization and Monitoring of Response to Prostate CanceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201021:01MarketwiredMolecular Insight Announces Resignation of Chief Medical OfficerNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
15/10/201022:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
15/10/201022:13MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/10/201021:49MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for DetecNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/10/201013:00MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LettersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201017:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201016:47MarketwiredMolecular Insight Receives Eleventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201019:58Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201019:51Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201016:16MarketwiredMolecular Insight Receives Tenth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201015:04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201013:00MarketwiredMolecular Insight Receives Ninth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/09/201020:38Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:MIPI

Your Recent History

LSE
PET
Petrel Resources
LSE
GOLD
LSE
SYME
Supply@me Capital
LSE
GFM
Griffin Mining
LSE
VAST
Vast Resources
LSE
CNR
Condor Gold
LSE
ITV
Itv
LSE
ALBA
Alba Mineral Resources
LSE
TERN
Tern
LSE
BBSN
Brave Bison
LSE
INSG
Insig Ai
LSE
JSE
Jadestone Energy
LSE
AAU
Ariana Resources
LSE
LTI
Lindsell Train Investment
LSE
HE1
Helium One Global
LSE
SCE
Surface Transforms
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved